NCT03009279

Brief Summary

To investigate the association between metabolic syndrome (MS) and thyroid nodule(s).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 26, 2016

Completed
6 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 4, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

January 9, 2017

Status Verified

January 1, 2017

Enrollment Period

10 months

First QC Date

December 26, 2016

Last Update Submit

January 5, 2017

Conditions

Metabolic SyndromeThyroid Nodule

Keywords

blood pressurefasting plasma glucosethyroid stimulating hormone

Outcome Measures

Primary Outcomes (1)

  • The laboratory examinations

    Lipids,glucose,thyroid functions

    In 2013-2015

Secondary Outcomes (1)

  • Blood pressure of patients in each group

    In 2013-2015

Other Outcomes (3)

  • BMI of patients in each group

    In 2013-2015

  • Age of patients in each group

    In 2013-2015

  • Gender of patients in each group

    In 2013-2015

Study Arms (2)

The MS group

Patients with metabolic syndrome(MS).

The non-MS group

Patients without metabolic syndrome(MS).

Eligibility Criteria

Age15 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.

You may qualify if:

  • People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
  • signed the informed consent.
  • Have complete clinical data.

You may not qualify if:

  • Patients with previous history of thyroid disease other than thyroid nodules.
  • People with abnormal thyroid function.
  • Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Metabolic SyndromeThyroid Nodule

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesThyroid NeoplasmsEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Officials

  • Lin Liao

    Qianfoshan Hospital

    STUDY CHAIR

Central Study Contacts

Lin Liao, MD

CONTACT

8615168888260liaolin@medmail.com.cn

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
chief of endocrinology department at Qianfoshan Hospital

Study Record Dates

First Submitted

December 26, 2016

First Posted

January 4, 2017

Study Start

January 1, 2017

Primary Completion

November 1, 2017

Study Completion

December 1, 2017

Last Updated

January 9, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will share